Stay updated on PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial

Sign up to get notified when there's something new on the PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A new revision entry is added to the record history (v3.5.4) replacing the previous revision (v3.5.3). This reflects an updated version of the page metadata rather than substantive changes to the trial data.
    Difference
    0.1%
    Check dated 2026-05-16T10:10:40.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    Change Detected
    Summary
    The page’s footer revision indicator was updated from v3.5.0 to v3.5.3. This reflects a change to the site’s versioning rather than any updates to the clinical trial record itself.
    Difference
    0.1%
    Check dated 2026-04-25T05:24:48.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 in the record history.
    Difference
    0.1%
    Check dated 2026-03-20T03:50:53.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Added revision v3.4.3 and removed revision v3.4.2 in the record history.
    Difference
    0.1%
    Check dated 2026-03-12T21:27:13.000Z thumbnail image
  7. Check
    94 days ago
    Change Detected
    Summary
    A minor update to the record history shows a new revision v3.4.2 added and v3.4.1 removed, with no substantive study content affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:10:49.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    The Record History shows a new revision (v3.4.1) added and the previous revision (v3.4.0) removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T22:49:04.000Z thumbnail image

Stay in the know with updates to PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial page.